Literature DB >> 9472506

Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test.

W M Simpson1, F D Johnstone, F M Boyd, D J Goldberg, G J Hart, R J Prescott.   

Abstract

OBJECTIVE: To determine the uptake and acceptability of different methods of a universal offer of voluntary HIV testing to pregnant women.
DESIGN: Randomised controlled trial involving four combinations of written and verbal communication, followed by the direct offer of a test. The control group received no information and no direct offer of a test, although testing was available on request.
SETTING: Hospital antenatal clinic covering most of the population of the city of Edinburgh.
SUBJECTS: 3024 pregnant women booking at the clinic over a 10 month period. MAIN OUTCOME MEASURES: Uptake of HIV testing and women's knowledge, satisfaction, and anxiety.
RESULTS: Uptake rates were 6% for those in the control group and 35% for those directly offered the test. Neither the style of leaflet nor the length of discussion had an effect on uptake. Significant independent predictors of uptake were a direct test offer; the midwife seen; and being unmarried, previously tested, and younger age. Knowledge of the specific benefits of testing increased with the amount of information given, but neither satisfaction nor anxiety was affected by the type of offer.
CONCLUSIONS: The universal offer of HIV testing is not intrusive and is acceptable to pregnant women. A policy of offering the HIV test to all women resulted in higher uptake and did not increase anxiety or dissatisfaction. Uptake depends more on the midwife than the method of offering the test. Low uptake rates and inadequate detection of HIV infection point to the need to assess a more routine approach to testing.

Entities:  

Mesh:

Year:  1998        PMID: 9472506      PMCID: PMC2665496          DOI: 10.1136/bmj.316.7127.262

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  24 in total

1.  Sexually transmitted infections in primary care: a need for education.

Authors:  P Matthews; J Fletcher
Journal:  Br J Gen Pract       Date:  2001-01       Impact factor: 5.386

2.  Antenatal HIV testing: assessment of a routine voluntary approach.

Authors:  W M Simpson; F D Johnstone; D J Goldberg; S M Gormley; G J Hart
Journal:  BMJ       Date:  1999-06-19

Review 3.  Increasing informed uptake and non-uptake of screening: evidence from a systematic review.

Authors:  R G Jepson; C A Forbes; A J Sowden; R A Lewis
Journal:  Health Expect       Date:  2001-06       Impact factor: 3.377

4.  Failure to prevent perinatal HIV infection.

Authors:  Ari Bitnun; Susan M King; Cheryl Arneson; Stanley E Read
Journal:  CMAJ       Date:  2002-04-02       Impact factor: 8.262

5.  A measure of informed choice.

Authors:  T M Marteau; E Dormandy; S Michie
Journal:  Health Expect       Date:  2001-06       Impact factor: 3.377

Review 6.  Opt in or opt out: what is optimal for prenatal screening for HIV infection?

Authors:  Sharon Walmsley
Journal:  CMAJ       Date:  2003-03-18       Impact factor: 8.262

Review 7.  The utilization of testing and counseling for HIV: a review of the social and behavioral evidence.

Authors:  Carla Makhlouf Obermeyer; Michelle Osborn
Journal:  Am J Public Health       Date:  2007-08-29       Impact factor: 9.308

Review 8.  Improving communication between health professionals and women in maternity care: a structured review.

Authors:  Rachel E Rowe; Jo Garcia; Alison J Macfarlane; Leslie L Davidson
Journal:  Health Expect       Date:  2002-03       Impact factor: 3.377

9.  Prenatal HIV tests. Routine testing or informed choice?

Authors:  Dale Guenter; Janusz Kaczorowski; June Carroll; John Sellors
Journal:  Can Fam Physician       Date:  2003-10       Impact factor: 3.275

10.  Acceptability of intrapartum HIV counselling and testing in Cameroon.

Authors:  Eugene J Kongnyuy; Enow R Mbu; Francois X Mbopi-Keou; Nelson Fomulu; Philip N Nana; Pierre M Tebeu; Rebecca N Tonye; Robert J I Leke
Journal:  BMC Pregnancy Childbirth       Date:  2009-02-27       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.